Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.
Stabile LP, Egloff AM, Gibson MK, Gooding WE, Ohr J, Zhou P, Rothenberger NJ, Wang L, Geiger JL, Flaherty JT, Grandis JR, Bauman JE. Stabile LP, et al. Among authors: gibson mk. Oral Oncol. 2017 Jun;69:38-45. doi: 10.1016/j.oraloncology.2017.03.011. Epub 2017 Apr 9. Oral Oncol. 2017. PMID: 28559019 Free PMC article. Clinical Trial.
Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx.
Walvekar RR, Li RJ, Gooding WE, Gibson MK, Heron D, Johnson JT, Ferris RL. Walvekar RR, et al. Among authors: gibson mk. Laryngoscope. 2008 Dec;118(12):2129-34. doi: 10.1097/MLG.0b013e3181857950. Laryngoscope. 2008. PMID: 18948826
Cetuximab-induced aseptic meningitis.
Feinstein TM, Gibson MK, Argiris A. Feinstein TM, et al. Among authors: gibson mk. Ann Oncol. 2009 Sep;20(9):1609-1610. doi: 10.1093/annonc/mdp382. Epub 2009 Jul 30. Ann Oncol. 2009. PMID: 19643807 Free article. No abstract available.
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Passero VA, Branstetter BF, Shuai Y, Heron DE, Gibson MK, Lai SY, Kim SW, Grandis JR, Ferris RL, Johnson JT, Argiris A. Passero VA, et al. Among authors: gibson mk. Ann Oncol. 2010 Nov;21(11):2278-2283. doi: 10.1093/annonc/mdq226. Epub 2010 Apr 29. Ann Oncol. 2010. PMID: 20430907 Free PMC article.
The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
Rwigema JC, Heron DE, Ferris RL, Andrade RS, Gibson MK, Yang Y, Ozhasoglu C, Argiris AE, Grandis JR, Burton SA. Rwigema JC, et al. Among authors: gibson mk. Am J Clin Oncol. 2011 Aug;34(4):372-9. doi: 10.1097/COC.0b013e3181e84dc0. Am J Clin Oncol. 2011. PMID: 20859194 Free PMC article.
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.
Argiris A, Heron DE, Smith RP, Kim S, Gibson MK, Lai SY, Branstetter BF, Posluszny DM, Wang L, Seethala RR, Dacic S, Gooding W, Grandis JR, Johnson JT, Ferris RL. Argiris A, et al. Among authors: gibson mk. J Clin Oncol. 2010 Dec 20;28(36):5294-300. doi: 10.1200/JCO.2010.30.6423. Epub 2010 Nov 15. J Clin Oncol. 2010. PMID: 21079141 Free PMC article.
118 results